These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 10099437)

  • 1. Serum-free ex vivo expansion of CD34(+) hematopoietic progenitor cells.
    Möbest D; Mertelsmann R; Henschler R
    Biotechnol Bioeng; 1998 Nov; 60(3):341-7. PubMed ID: 10099437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin.
    Brugger W; Möcklin W; Heimfeld S; Berenson RJ; Mertelsmann R; Kanz L
    Blood; 1993 May; 81(10):2579-84. PubMed ID: 7683923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
    Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
    J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: duration of culture; the media, serum supplements, and growth factors used; and engraftment in NOD/SCID mice.
    Lam AC; Li K; Zhang XB; Li CK; Fok TF; Chang AM; James AE; Tsang KS; Yuen PM
    Transfusion; 2001 Dec; 41(12):1567-76. PubMed ID: 11778074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ex vivo expansion capacity of normal human bone marrow cells is dependent on experimental conditions: role of the cell concentration, serum and CD34+ cell selection in stroma-free cultures.
    Poloni A; Giarratana MC; Firat H; Kobari L; Gorin NC; Douay L
    Hematol Cell Ther; 1997 Apr; 39(2):49-58. PubMed ID: 9168300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta 1 delays formation of granulocyte-macrophage colony-forming cells, but spares more primitive progenitors during ex vivo expansion of CD34+ haemopoietic progenitor cells.
    Garbe A; Spyridonidis A; Möbest D; Schmoor C; Mertelsmann R; Henschler R
    Br J Haematol; 1997 Dec; 99(4):951-8. PubMed ID: 9432049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of transplantation potential in ex vivo expanded CD34(+)-selected human peripheral blood progenitor cells.
    Henschler R; Brugger W; Luft T; Frey T; Mertelsmann R; Kanz L
    Blood; 1994 Nov; 84(9):2898-903. PubMed ID: 7524757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal factors support the expansion of the whole hemopoietic spectrum from bone marrow CD34+DR- cells and of some hemopoietic subsets from CD34+ and CD34+DR+ cells.
    Herman P; Ferrant A; De Bruyère M; Straetmans N
    Leukemia; 1998 May; 12(5):735-45. PubMed ID: 9593272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of functional myeloid cells from CD34-selected hematopoietic progenitor cells using a clinically relevant ex vivo expansion system.
    Lill MC; Lynch M; Fraser JK; Chung GY; Schiller G; Glaspy JA; Souza L; Baldwin GC; Gasson JC
    Stem Cells; 1994 Nov; 12(6):626-37. PubMed ID: 7533581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal serum-free culture of purified human CD34+ cells: amplification of progenitors from G-CSF and GM-CSF-mobilized peripheral blood.
    Schain LR; Jain S; Wysocki M; Hall M; Dadey B; Pennathur-Das R; Biddle W; Wolf J; Okarma TB; Lebkowski JS
    J Hematother; 1997 Aug; 6(4):335-49. PubMed ID: 9377072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells.
    Scheding S; Meister B; Bühring HJ; Baum CM; Mc Kearn JP; Bock T; Kanz L; Brugger W
    Exp Hematol; 2000 Apr; 28(4):460-70. PubMed ID: 10781904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A stromal-free, serum-free system to expand ex vivo hematopoietic stem cells from mobilized peripheral blood of patients with hematologic malignancies and healthy donors.
    Yao CL; Hsu SC; Hwang SM; Lee WC; Chiou TJ
    Cytotherapy; 2013 Sep; 15(9):1126-35. PubMed ID: 23768928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term culture-initiating cell expansion is dependent on frequent medium exchange combined with stromal and other accessory cell effects.
    Koller MR; Palsson MA; Manchel I; Palsson BO
    Blood; 1995 Sep; 86(5):1784-93. PubMed ID: 7544642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo expansion of CD34+ peripheral blood progenitor cells: implications for the expansion of contaminating epithelial tumor cells.
    Vogel W; Behringer D; Scheding S; Kanz L; Brugger W
    Blood; 1996 Oct; 88(7):2707-13. PubMed ID: 8839866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of mobilized peripheral blood progenitor cells under defined culture conditions rsing CD34+CD71-CD45- cells as a starting population.
    Zech NH; Gunsilius E; Clausen J; Hoflehner E; Hoelzler K; Gastl G; Petzer AL
    J Hematother Stem Cell Res; 2003 Aug; 12(4):367-73. PubMed ID: 12965074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet released growth factors boost expansion of bone marrow derived CD34(+) and CD133(+) endothelial progenitor cells for autologous grafting.
    Lippross S; Loibl M; Hoppe S; Meury T; Benneker L; Alini M; Verrier S
    Platelets; 2011; 22(6):422-32. PubMed ID: 21473675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.